Conor Medsystems, J&J deal

JNJ agreed to acquire drug-eluting stent company CONR for $33.50 per

Read the full 113 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE